Hepatitis C Drug 'Price Wars' Unlikely to Boost Access to the Medications
February 3, 2015
Stacey Trooskin, MD, PhD, an assistant professor in the College of Medicine, was quoted in a Feb. 3 Everyday Health article about how price wars over new medications to treat Hepatitis C are unlikely to boost access for patients who need treatment.
Related:
Drexel News is produced by
University Marketing and Communications.